{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:35:43Z","timestamp":1790962543772,"version":"4.1.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104724"],"award-info":[{"award-number":["82104724"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Undergraduate Students' Innovation Training Program of Jiangsu Province","award":["202411117052Z"],"award-info":[{"award-number":["202411117052Z"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00213-025-06839-2","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:04:30Z","timestamp":1750050270000},"page":"2161-2179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The orexin\/hypocretin system in dementia-related neurological disorders: a double-edged sword in cognitive impairment"],"prefix":"10.1007","volume":"242","author":[{"given":"Chenyu","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-0503","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"6839_CR1","doi-asserted-by":"publisher","unstructured":"Aarsland D (2020) Epidemiology and pathophysiology of Dementia-related psychosis. J Clin Psychiatry 81(5). https:\/\/doi.org\/10.4088\/jcp.Ad19038br1c","DOI":"10.4088\/jcp.Ad19038br1c"},{"issue":"8","key":"6839_CR2","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1073\/pnas.85.8.2706","volume":"85","author":"R Adelman","year":"1988","unstructured":"Adelman R, Saul RL, Ames BN (1988) Oxidative damage to DNA: relation to species metabolic rate and life span. Proc Natl Acad Sci U S A 85(8):2706\u20132708. https:\/\/doi.org\/10.1073\/pnas.85.8.2706","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6839_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbr.2006.05.028","volume":"173","author":"E Akbari","year":"2006","unstructured":"Akbari E, Naghdi N, Motamedi F (2006) Functional inactivation of orexin 1 receptors in CA1 region impairs acquisition, consolidation and retrieval in Morris water maze task. Behav Brain Res 173(1):47\u201352. https:\/\/doi.org\/10.1016\/j.bbr.2006.05.028","journal-title":"Behav Brain Res"},{"issue":"1","key":"6839_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbr.2007.09.019","volume":"187","author":"E Akbari","year":"2008","unstructured":"Akbari E, Motamedi F, Naghdi N, Noorbakhshnia M (2008) The effect of antagonization of orexin 1 receptors in CA1 and dentate gyrus regions on memory processing in passive avoidance task. Behav Brain Res 187(1):172\u2013177. https:\/\/doi.org\/10.1016\/j.bbr.2007.09.019","journal-title":"Behav Brain Res"},{"issue":"2","key":"6839_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1124\/jpet.102.048025","volume":"305","author":"S Ammoun","year":"2003","unstructured":"Ammoun S, Holmqvist T, Shariatmadari R, Oonk HB, Detheux M, Parmentier M et al (2003) Distinct recognition of OX1 and OX2 receptors by orexin peptides. J Pharmacol Exp Ther 305(2):507\u2013514. https:\/\/doi.org\/10.1124\/jpet.102.048025","journal-title":"J Pharmacol Exp Ther"},{"key":"6839_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainres.2009.09.106","volume":"1314","author":"G Aston-Jones","year":"2010","unstructured":"Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili-Fahadan P et al (2010) Lateral hypothalamic orexin\/hypocretin neurons: A role in reward-seeking and addiction. Brain Res 1314:74\u201390. https:\/\/doi.org\/10.1016\/j.brainres.2009.09.106","journal-title":"Brain Res"},{"issue":"4","key":"6839_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1750-3639.2008.00135.x","volume":"18","author":"A Aziz","year":"2008","unstructured":"Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F, Overeem S et al (2008) Hypocretin and melanin-concentrating hormone in patients with Huntington disease. Brain Pathol 18(4):474\u2013483. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00135.x","journal-title":"Brain Pathol"},{"issue":"2","key":"6839_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000079749","volume":"52","author":"CR Baumann","year":"2004","unstructured":"Baumann CR, Dauvilliers Y, Mignot E, Bassetti CL (2004) Normal CSF hypocretin-1 (orexin A) levels in dementia with lewy bodies associated with excessive daytime sleepiness. Eur Neurol 52(2):73\u201376. https:\/\/doi.org\/10.1159\/000079749","journal-title":"Eur Neurol"},{"issue":"9","key":"6839_CR9","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s00415-006-0146-7","volume":"253","author":"CR Baumann","year":"2006","unstructured":"Baumann CR, Hersberger M, Bassetti CL (2006) Hypocretin-1 (orexin A) levels are normal in Huntington\u2019s disease. J Neurol 253(9):1232\u20131233. https:\/\/doi.org\/10.1007\/s00415-006-0146-7","journal-title":"J Neurol"},{"issue":"6","key":"6839_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2174\/156720511796717230","volume":"8","author":"K Belarbi","year":"2011","unstructured":"Belarbi K, Burnouf S, Fernandez-Gomez FJ, Desmerci\u00e8res J, Troquier L, Brouillette J et al (2011) Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with Tau pathology? Curr Alzheimer Res 8(6):633\u2013638. https:\/\/doi.org\/10.2174\/156720511796717230","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"6839_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/ejn.12761","volume":"41","author":"M Bensaid","year":"2015","unstructured":"Bensaid M, Tand\u00e9 D, Fabre V, Michel PP, Hirsch EC, Fran\u00e7ois C (2015) Sparing of orexin-A and orexin-B neurons in the hypothalamus and of orexin fibers in the substantia Nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated macaques. Eur J Neurosci 41(1):129\u2013136. https:\/\/doi.org\/10.1111\/ejn.12761","journal-title":"Eur J Neurosci"},{"issue":"20","key":"6839_CR12","doi-asserted-by":"publisher","first-page":"8164","DOI":"10.1523\/jneurosci.21-20-08164.2001","volume":"21","author":"J Berger-Sweeney","year":"2001","unstructured":"Berger-Sweeney J, Stearns NA, Murg SL, Floerke-Nashner LR, Lappi DA, Baxter MG (2001) Selective immunolesions of cholinergic neurons in mice: effects on neuroanatomy, neurochemistry, and behavior. J Neurosci 21(20):8164\u20138173. https:\/\/doi.org\/10.1523\/jneurosci.21-20-08164.2001","journal-title":"J Neurosci"},{"issue":"3","key":"6839_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3233\/jad-201054","volume":"81","author":"CT Beuckmann","year":"2021","unstructured":"Beuckmann CT, Suzuki H, Musiek ES, Ueno T, Sato T, Bando M et al (2021) Evaluation of SAMP8 mice as a model for Sleep-Wake and rhythm disturbances associated with alzheimer\u2019s disease: impact of treatment with the dual orexin (Hypocretin) receptor antagonist lemborexant. J Alzheimers Dis 81(3):1151\u20131167. https:\/\/doi.org\/10.3233\/jad-201054","journal-title":"J Alzheimers Dis"},{"key":"6839_CR14","doi-asserted-by":"publisher","first-page":"136291","DOI":"10.1016\/j.neulet.2021.136291","volume":"765","author":"K Bian","year":"2021","unstructured":"Bian K, Liu C, Wang Y, Xue Y, Chen L (2021) Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice. Neurosci Lett 765:136291. https:\/\/doi.org\/10.1016\/j.neulet.2021.136291","journal-title":"Neurosci Lett"},{"issue":"1","key":"6839_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1515\/bmc-2016-0029","volume":"8","author":"M Bol\u00f3s","year":"2017","unstructured":"Bol\u00f3s M, Perea JR, \u00c1vila J (2017) Alzheimer\u2019s disease as an inflammatory disease. Biomol Concepts 8(1):37\u201343. https:\/\/doi.org\/10.1515\/bmc-2016-0029","journal-title":"Biomol Concepts"},{"issue":"3","key":"6839_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/jpd-240002","volume":"14","author":"P Borghammer","year":"2024","unstructured":"Borghammer P, Okkels N, Weintraub D (2024) Parkinson\u2019s disease and dementia with lewy bodies: one and the same. J Parkinsons Dis 14(3):383\u2013397. https:\/\/doi.org\/10.3233\/jpd-240002","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"6839_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00213-009-1596-2","volume":"206","author":"KE Boschen","year":"2009","unstructured":"Boschen KE, Fadel JR, Burk JA (2009) Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats. Psychopharmacology 206(2):205\u2013213. https:\/\/doi.org\/10.1007\/s00213-009-1596-2","journal-title":"Psychopharmacology"},{"issue":"4","key":"6839_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259. https:\/\/doi.org\/10.1007\/bf00308809","journal-title":"Acta Neuropathol"},{"key":"6839_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/nss.S41245","volume":"5","author":"A Bridoux","year":"2013","unstructured":"Bridoux A, Moutereau S, Covali-Noroc A, Margarit L, Palfi S, Nguyen JP et al (2013) Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without Atonia in Parkinson\u2019s disease. Nat Sci Sleep 5:87\u201391. https:\/\/doi.org\/10.2147\/nss.S41245","journal-title":"Nat Sci Sleep"},{"issue":"3","key":"6839_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s13311-019-00726-3","volume":"16","author":"M Cabanas","year":"2019","unstructured":"Cabanas M, Pistono C, Puygrenier L, Rakesh D, Jeantet Y, Garret M et al (2019) Neurophysiological and behavioral effects of anti-orexinergic treatments in a mouse model of Huntington\u2019s disease. Neurotherapeutics 16(3):784\u2013796. https:\/\/doi.org\/10.1007\/s13311-019-00726-3","journal-title":"Neurotherapeutics"},{"issue":"3","key":"6839_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jnc.14279","volume":"145","author":"CB Calva","year":"2018","unstructured":"Calva CB, Fayyaz H, Fadel JR (2018) Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1). J Neurochem 145(3):232\u2013244. https:\/\/doi.org\/10.1111\/jnc.14279","journal-title":"J Neurochem"},{"key":"6839_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fnagi.2019.00362","volume":"11","author":"CB Calva","year":"2019","unstructured":"Calva CB, Fayyaz H, Fadel JR (2019) Effects of intranasal Orexin-A (Hypocretin-1) administration on neuronal activation, neurochemistry, and attention in aged rats. Front Aging Neurosci 11:362. https:\/\/doi.org\/10.3389\/fnagi.2019.00362","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"6839_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/wnr.0000000000000364","volume":"26","author":"MT Castaneda","year":"2015","unstructured":"Castaneda MT, Lopez ED, Touhami A, Tovar R, Ortega MR, Rodriguez JM (2015) Neuroprotection of medial septal cholinergic neurons by memantine after intralateral septal injection of A\u03b21\u201340. NeuroReport 26(8):450\u2013454. https:\/\/doi.org\/10.1097\/wnr.0000000000000364","journal-title":"NeuroReport"},{"key":"6839_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.smrv.2016.02.002","volume":"31","author":"J Cedernaes","year":"2017","unstructured":"Cedernaes J, Osorio RS, Varga AW, Kam K, Schi\u00f6th HB, Benedict C (2017) Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer\u2019s disease. Sleep Med Rev 31:102\u2013111. https:\/\/doi.org\/10.1016\/j.smrv.2016.02.002","journal-title":"Sleep Med Rev"},{"issue":"3","key":"6839_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s0304-3940(98)00977-x","volume":"260","author":"CT Chen","year":"1999","unstructured":"Chen CT, Dun SL, Kwok EH, Dun NJ, Chang JK (1999) Orexin A-like immunoreactivity in the rat brain. Neurosci Lett 260(3):161\u2013164. https:\/\/doi.org\/10.1016\/s0304-3940(98)00977-x","journal-title":"Neurosci Lett"},{"key":"6839_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/nss.S76711","volume":"8","author":"M Chow","year":"2016","unstructured":"Chow M, Cao M (2016) The hypocretin\/orexin system in sleep disorders: preclinical insights and clinical progress. Nat Sci Sleep 8:81\u201386. https:\/\/doi.org\/10.2147\/nss.S76711","journal-title":"Nat Sci Sleep"},{"issue":"Pt 12","key":"6839_CR27","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1093\/brain\/awp263","volume":"132","author":"Y Compta","year":"2009","unstructured":"Compta Y, Santamaria J, Ratti L, Tolosa E, Iranzo A, Mu\u00f1oz E et al (2009) Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson\u2019s disease dementia. Brain 132(Pt 12):3308\u20133317. https:\/\/doi.org\/10.1093\/brain\/awp263","journal-title":"Brain"},{"issue":"5","key":"6839_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12264-010-0410-9","volume":"26","author":"LB Cui","year":"2010","unstructured":"Cui LB, Li BW, Jin XH, Zhao L, Shi J (2010) Progressive changes of orexin system in a rat model of 6-hydroxydopamine-induced Parkinson\u2019s disease. Neurosci Bull 26(5):381\u2013387. https:\/\/doi.org\/10.1007\/s12264-010-0410-9","journal-title":"Neurosci Bull"},{"issue":"6","key":"6839_CR29","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.neuint.2011.07.005","volume":"59","author":"W Cui","year":"2011","unstructured":"Cui W, Li W, Han R, Mak S, Zhang H, Hu S et al (2011) PI3-K\/Akt and ERK pathways activated by VEGF play opposite roles in MPP+-induced neuronal apoptosis. Neurochem Int 59(6):945\u2013953. https:\/\/doi.org\/10.1016\/j.neuint.2011.07.005","journal-title":"Neurochem Int"},{"key":"6839_CR30","doi-asserted-by":"publisher","first-page":"101308","DOI":"10.1016\/j.smrv.2020.101308","volume":"52","author":"AL D\u2019Rozario","year":"2020","unstructured":"D\u2019Rozario AL, Chapman JL, Phillips CL, Palmer JR, Hoyos CM, Mowszowski L et al (2020) Objective measurement of sleep in mild cognitive impairment: a systematic review and meta-analysis. Sleep Med Rev 52:101308. https:\/\/doi.org\/10.1016\/j.smrv.2020.101308","journal-title":"Sleep Med Rev"},{"issue":"22","key":"6839_CR31","doi-asserted-by":"publisher","first-page":"8394","DOI":"10.1523\/jneurosci.4460-14.2015","volume":"35","author":"H Dannenberg","year":"2015","unstructured":"Dannenberg H, Pabst M, Braganza O, Schoch S, Niediek J, Bayraktar M et al (2015) Synergy of direct and indirect cholinergic septo-hippocampal pathways coordinates firing in hippocampal networks. J Neurosci 35(22):8394\u20138410. https:\/\/doi.org\/10.1523\/jneurosci.4460-14.2015","journal-title":"J Neurosci"},{"key":"6839_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000514967","volume":"45","author":"Y Dauvilliers","year":"2021","unstructured":"Dauvilliers Y (2021) Hypocretin\/Orexin, sleep and Alzheimer\u2019s disease. Front Neurol Neurosci 45:139\u2013149. https:\/\/doi.org\/10.1159\/000514967","journal-title":"Front Neurol Neurosci"},{"issue":"12","key":"6839_CR33","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","volume":"74","author":"Y Dauvilliers","year":"2003","unstructured":"Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, Lecendreux M et al (2003) CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 74(12):1667\u20131673. https:\/\/doi.org\/10.1136\/jnnp.74.12.1667","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8000","key":"6839_CR34","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/s0140-6736(76)91936-x","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet 2(8000):1403. https:\/\/doi.org\/10.1016\/s0140-6736(76)91936-x","journal-title":"Lancet"},{"issue":"1","key":"6839_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L de Lecea","year":"1998","unstructured":"de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE et al (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95(1):322\u2013327. https:\/\/doi.org\/10.1073\/pnas.95.1.322","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6839_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neulet.2013.12.036","volume":"561","author":"M Deuschle","year":"2014","unstructured":"Deuschle M, Schilling C, Leweke FM, Enning F, Pollm\u00e4cher T, Esselmann H et al (2014) Hypocretin in cerebrospinal fluid is positively correlated with Tau and pTau. Neurosci Lett 561:41\u201345. https:\/\/doi.org\/10.1016\/j.neulet.2013.12.036","journal-title":"Neurosci Lett"},{"issue":"4","key":"6839_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1212\/01.wnl.0000078194.53210.48","volume":"61","author":"X Drouot","year":"2003","unstructured":"Drouot X, Moutereau S, Nguyen JP, Lefaucheur JP, Cr\u00e9ange A, Remy P et al (2003) Low levels of ventricular CSF orexin\/hypocretin in advanced PD. Neurology 61(4):540\u2013543. https:\/\/doi.org\/10.1212\/01.wnl.0000078194.53210.48","journal-title":"Neurology"},{"key":"6839_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2015.08.033","volume":"606","author":"CM Duffy","year":"2015","unstructured":"Duffy CM, Yuan C, Wisdorf LE, Billington CJ, Kotz CM, Nixon JP et al (2015) Role of orexin A signaling in dietary palmitic acid-activated microglial cells. Neurosci Lett 606:140\u2013144. https:\/\/doi.org\/10.1016\/j.neulet.2015.08.033","journal-title":"Neurosci Lett"},{"key":"6839_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nlm.2018.11.008","volume":"157","author":"CM Duffy","year":"2019","unstructured":"Duffy CM, Hofmeister JJ, Nixon JP, Butterick TA (2019) High fat diet increases cognitive decline and neuroinflammation in a model of orexin loss. Neurobiol Learn Mem 157:41\u201347. https:\/\/doi.org\/10.1016\/j.nlm.2018.11.008","journal-title":"Neurobiol Learn Mem"},{"issue":"4","key":"6839_CR40","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/s0306-4522(01)00319-0","volume":"106","author":"RA Espa\u00f1a","year":"2001","unstructured":"Espa\u00f1a RA, Baldo BA, Kelley AE, Berridge CW (2001) Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106(4):699\u2013715. https:\/\/doi.org\/10.1016\/s0306-4522(01)00319-0","journal-title":"Neuroscience"},{"issue":"4","key":"6839_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12264-009-0416-3","volume":"25","author":"Y Fan","year":"2009","unstructured":"Fan Y, Zhang YQ, Sun DJ, Zhang YN, Wu XW, Li J (2009) Rottlerin protected dopaminergic cell line from cytotoxicity of 6-hydroxydopamine by inhibiting PKCdelta phosphorylation. Neurosci Bull 25(4):187\u2013195. https:\/\/doi.org\/10.1007\/s12264-009-0416-3","journal-title":"Neurosci Bull"},{"issue":"4","key":"6839_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1556\/ABiol.53.2002.4.5","volume":"53","author":"B Farkas","year":"2002","unstructured":"Farkas B, Vil\u00e1gi I, D\u00e9t\u00e1ri L (2002) Effect of orexin-A on discharge rate of rat Suprachiasmatic nucleus neurons in vitro. Acta Biol Hung 53(4):435\u2013443. https:\/\/doi.org\/10.1556\/ABiol.53.2002.4.5","journal-title":"Acta Biol Hung"},{"key":"6839_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neulet.2014.07.014","volume":"579","author":"Y Feng","year":"2014","unstructured":"Feng Y, Liu T, Li XQ, Liu Y, Zhu XY, Jankovic J et al (2014) Neuroprotection by orexin-A via HIF-1\u03b1 induction in a cellular model of Parkinson\u2019s disease. Neurosci Lett 579:35\u201340. https:\/\/doi.org\/10.1016\/j.neulet.2014.07.014","journal-title":"Neurosci Lett"},{"issue":"1","key":"6839_CR44","doi-asserted-by":"publisher","first-page":"e86240","DOI":"10.1371\/journal.pone.0086240","volume":"9","author":"K Fifel","year":"2014","unstructured":"Fifel K, Vezoli J, Dzahini K, Claustrat B, Leviel V, Kennedy H et al (2014) Alteration of daily and circadian rhythms following dopamine depletion in MPTP treated non-human primates. PLoS ONE 9(1):e86240. https:\/\/doi.org\/10.1371\/journal.pone.0086240","journal-title":"PLoS ONE"},{"issue":"1","key":"6839_CR45","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.1038\/s41467-021-26388-4","volume":"12","author":"N Forte","year":"2021","unstructured":"Forte N, Boccella S, Tunisi L, Fern\u00e1ndez-Rilo AC, Imperatore R, Iannotti FA et al (2021) Orexin-A and endocannabinoids are involved in obesity-associated alteration of hippocampal neurogenesis, plasticity, and episodic memory in mice. Nat Commun 12(1):6137. https:\/\/doi.org\/10.1038\/s41467-021-26388-4","journal-title":"Nat Commun"},{"key":"6839_CR46","doi-asserted-by":"publisher","first-page":"1004002","DOI":"10.3389\/fnagi.2022.1004002","volume":"14","author":"N Forte","year":"2022","unstructured":"Forte N, Fern\u00e1ndez-Rilo AC, Palomba L, Marfella B, Piscitelli F, De Girolamo P et al (2022) Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer\u2019s disease. Front Aging Neurosci 14:1004002. https:\/\/doi.org\/10.3389\/fnagi.2022.1004002","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"6839_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","volume":"66","author":"PT Francis","year":"1999","unstructured":"Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. J Neurol Neurosurg Psychiatry 66(2):137\u2013147. https:\/\/doi.org\/10.1136\/jnnp.66.2.137","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"6839_CR48","doi-asserted-by":"publisher","first-page":"e093087","DOI":"10.1002\/alz.093087","volume":"20","author":"MA Frick","year":"2024","unstructured":"Frick MA, Somera BL, Woodruff JL, Reagan LP, Fadel JR (2024) Basic science and pathogenesis. Alzheimers Dement 20(Suppl 1):e093087. https:\/\/doi.org\/10.1002\/alz.093087","journal-title":"Alzheimers Dement"},{"issue":"10","key":"6839_CR49","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1212\/01.wnl.0000256731.57544.f9","volume":"68","author":"LF Friedman","year":"2007","unstructured":"Friedman LF, Zeitzer JM, Lin L, Hoff D, Mignot E, Peskind ER et al (2007) In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1. Neurology 68(10):793\u2013794. https:\/\/doi.org\/10.1212\/01.wnl.0000256731.57544.f9","journal-title":"Neurology"},{"issue":"Pt 6","key":"6839_CR50","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/brain\/awm090","volume":"130","author":"R Fronczek","year":"2007","unstructured":"Fronczek R, Overeem S, Lee SY, Hegeman IM, van Pelt J, van Duinen SG et al (2007) Hypocretin (orexin) loss in Parkinson\u2019s disease. Brain 130(Pt 6):1577\u20131585. https:\/\/doi.org\/10.1093\/brain\/awm090","journal-title":"Brain"},{"issue":"8","key":"6839_CR51","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.neurobiolaging.2011.03.014","volume":"33","author":"R Fronczek","year":"2012","unstructured":"Fronczek R, van Geest S, Fr\u00f6lich M, Overeem S, Roelandse FW, Lammers GJ et al (2012) Hypocretin (orexin) loss in Alzheimer\u2019s disease. Neurobiol Aging 33(8):1642\u20131650. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.03.014","journal-title":"Neurobiol Aging"},{"key":"6839_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neurobiolaging.2017.01.011","volume":"53","author":"A Gabelle","year":"2017","unstructured":"Gabelle A, Jaussent I, Hirtz C, Vialaret J, Navucet S, Grasselli C et al (2017) Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process. Neurobiol Aging 53:59\u201366. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.01.011","journal-title":"Neurobiol Aging"},{"issue":"6","key":"6839_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-010-0742-6","volume":"120","author":"S Gabery","year":"2010","unstructured":"Gabery S, Murphy K, Schultz K, Loy CT, McCusker E, Kirik D et al (2010) Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses. Acta Neuropathol 120(6):777\u2013788. https:\/\/doi.org\/10.1007\/s00401-010-0742-6","journal-title":"Acta Neuropathol"},{"issue":"6","key":"6839_CR54","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1111\/j.1460-9568.2012.08193.x","volume":"36","author":"S Gabery","year":"2012","unstructured":"Gabery S, Sajjad MU, Hult S, Soylu R, Kirik D, Peters\u00e9n \u00c5 (2012) Characterization of a rat model of Huntington\u2019s disease based on targeted expression of mutant Huntingtin in the forebrain using adeno-associated viral vectors. Eur J Neurosci 36(6):2789\u20132800. https:\/\/doi.org\/10.1111\/j.1460-9568.2012.08193.x","journal-title":"Eur J Neurosci"},{"issue":"3","key":"6839_CR55","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3233\/jad-220082","volume":"88","author":"J Gan","year":"2022","unstructured":"Gan J, Liu S, Chen Z, Yang Y, Ma L, Meng Q et al (2022) Elevated plasma Orexin-A levels in prodromal dementia with lewy bodies. J Alzheimers Dis 88(3):1037\u20131048. https:\/\/doi.org\/10.3233\/jad-220082","journal-title":"J Alzheimers Dis"},{"key":"6839_CR56","doi-asserted-by":"publisher","first-page":"136247","DOI":"10.1016\/j.neulet.2021.136247","volume":"765","author":"F Gao","year":"2021","unstructured":"Gao F, Liu T, Tuo M, Chi S (2021) The role of orexin in Alzheimer disease: from sleep-wake disturbance to therapeutic target. Neurosci Lett 765:136247. https:\/\/doi.org\/10.1016\/j.neulet.2021.136247","journal-title":"Neurosci Lett"},{"issue":"12","key":"6839_CR57","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/sleep\/28.12.1607","volume":"28","author":"SE Gaus","year":"2005","unstructured":"Gaus SE, Lin L, Mignot E (2005) CSF hypocretin levels are normal in Huntington\u2019s disease patients. Sleep 28(12):1607\u20131608. https:\/\/doi.org\/10.1093\/sleep\/28.12.1607","journal-title":"Sleep"},{"issue":"2","key":"6839_CR58","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/s0014-4886(03)00388-1","volume":"184","author":"D Gerashchenko","year":"2003","unstructured":"Gerashchenko D, Murillo-Rodriguez E, Lin L, Xu M, Hallett L, Nishino S et al (2003) Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 184(2):1010\u20131016. https:\/\/doi.org\/10.1016\/s0014-4886(03)00388-1","journal-title":"Exp Neurol"},{"key":"6839_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-2094-10-16","volume":"10","author":"C Gomes","year":"2013","unstructured":"Gomes C, Ferreira R, George J, Sanches R, Rodrigues DI, Gon\u00e7alves N et al (2013) Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor Blockade prevents BDNF release and proliferation of microglia. J Neuroinflammation 10:16. https:\/\/doi.org\/10.1186\/1742-2094-10-16","journal-title":"J Neuroinflammation"},{"issue":"2","key":"6839_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1006\/nlme.1996.0016","volume":"65","author":"G Grigoryan","year":"1996","unstructured":"Grigoryan G, Hodges H, Mitchell S, Sinden JD, Gray JA (1996) 6-OHDA lesions of the nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system: effects of nicotine administration on learning and memory in the water maze. Neurobiol Learn Mem 65(2):135\u2013153. https:\/\/doi.org\/10.1006\/nlme.1996.0016","journal-title":"Neurobiol Learn Mem"},{"issue":"3","key":"6839_CR61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1124\/mol.114.095703","volume":"87","author":"S Guerreiro","year":"2015","unstructured":"Guerreiro S, Florence C, Rousseau E, Hamadat S, Hirsch EC, Michel PP (2015) The sleep-modulating peptide orexin-B protects midbrain dopamine neurons from degeneration, alone or in Cooperation with nicotine. Mol Pharmacol 87(3):525\u2013532. https:\/\/doi.org\/10.1124\/mol.114.095703","journal-title":"Mol Pharmacol"},{"issue":"9","key":"6839_CR62","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/01616412.2017.1352185","volume":"39","author":"Z Hadadianpour","year":"2017","unstructured":"Hadadianpour Z, Fatehi F, Ayoobi F, Kaeidi A, Shamsizadeh A, Fatemi I (2017) The effect of orexin-A on motor and cognitive functions in a rat model of Parkinson\u2019s disease. Neurol Res 39(9):845\u2013851. https:\/\/doi.org\/10.1080\/01616412.2017.1352185","journal-title":"Neurol Res"},{"issue":"2","key":"6839_CR63","doi-asserted-by":"publisher","first-page":"Ii58","DOI":"10.1007\/pl00007762","volume":"247","author":"EC Hirsch","year":"2000","unstructured":"Hirsch EC (2000) Glial cells and Parkinson\u2019s disease. J Neurol 247(2):Ii58\u201362. https:\/\/doi.org\/10.1007\/pl00007762","journal-title":"J Neurol"},{"key":"6839_CR64","doi-asserted-by":"publisher","first-page":"135480","DOI":"10.1016\/j.neulet.2020.135480","volume":"741","author":"S Huang","year":"2021","unstructured":"Huang S, Zhao Z, Ma J, Hu S, Li L, Wang Z et al (2021) Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson\u2019s disease patients. Neurosci Lett 741:135480. https:\/\/doi.org\/10.1016\/j.neulet.2020.135480","journal-title":"Neurosci Lett"},{"issue":"2","key":"6839_CR65","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tins.2022.11.006","volume":"46","author":"KM Igarashi","year":"2023","unstructured":"Igarashi KM (2023) Entorhinal cortex dysfunction in Alzheimer\u2019s disease. Trends Neurosci 46(2):124\u2013136. https:\/\/doi.org\/10.1016\/j.tins.2022.11.006","journal-title":"Trends Neurosci"},{"issue":"1","key":"6839_CR66","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/psyg.12618","volume":"21","author":"Y Inagawa","year":"2021","unstructured":"Inagawa Y, Shimizu S, Takenoshita N, Tsugawa A, Hirose D, Kanbayashi T et al (2021) Association between cerebrospinal fluid orexin A level and severity of rapid eye movement sleep behaviour disorder in dementia with lewy bodies. Psychogeriatrics 21(1):128\u2013130. https:\/\/doi.org\/10.1111\/psyg.12618","journal-title":"Psychogeriatrics"},{"issue":"5955","key":"6839_CR67","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"J-E Kang","year":"2009","unstructured":"Kang J-E, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR et al (2009) Amyloid-\u03b2 dynamics are regulated by orexin and the sleep-wake cycle. Science 326(5955):1005\u20131007. https:\/\/doi.org\/10.1126\/science.1180962","journal-title":"Science"},{"key":"6839_CR68","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.pneurobio.2020.101771","volume":"187","author":"MM Karnani","year":"2020","unstructured":"Karnani MM, Sch\u00f6ne C, Bracey EF, Gonz\u00e1lez JA, Viskaitis P, Li HT et al (2020) Role of spontaneous and sensory orexin network dynamics in rapid locomotion initiation. Prog Neurobiol 187:101771. https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101771","journal-title":"Prog Neurobiol"},{"key":"6839_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neulet.2014.03.020","volume":"569","author":"K Kasanuki","year":"2014","unstructured":"Kasanuki K, Iseki E, Kondo D, Fujishiro H, Minegishi M, Sato K et al (2014) Neuropathological investigation of hypocretin expression in brains of dementia with lewy bodies. Neurosci Lett 569:68\u201373. https:\/\/doi.org\/10.1016\/j.neulet.2014.03.020","journal-title":"Neurosci Lett"},{"issue":"2","key":"6839_CR70","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neures.2010.06.010","volume":"68","author":"E Kitamura","year":"2010","unstructured":"Kitamura E, Hamada J, Kanazawa N, Yonekura J, Masuda R, Sakai F et al (2010) The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia. Neurosci Res 68(2):154\u2013157. https:\/\/doi.org\/10.1016\/j.neures.2010.06.010","journal-title":"Neurosci Res"},{"issue":"1","key":"6839_CR71","doi-asserted-by":"publisher","first-page":"100004","DOI":"10.1016\/j.jphyss.2024.100004","volume":"75","author":"M Kourosh-Arami","year":"2025","unstructured":"Kourosh-Arami M, Ramezani M, Komaki A (2025) The interaction between orexin, sleep deprivation and Alzheimer\u2019s disease: unveiling an emerging connection. J Physiol Sci 75(1):100004. https:\/\/doi.org\/10.1016\/j.jphyss.2024.100004","journal-title":"J Physiol Sci"},{"key":"6839_CR72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","volume":"1078","author":"J Kovalevich","year":"2013","unstructured":"Kovalevich J, Langford D (2013) Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol 1078:9\u201321. https:\/\/doi.org\/10.1007\/978-1-62703-640-5_2","journal-title":"Methods Mol Biol"},{"issue":"1","key":"6839_CR73","doi-asserted-by":"publisher","first-page":"24788","DOI":"10.1038\/s41598-024-76237-9","volume":"14","author":"GM Krause","year":"2024","unstructured":"Krause GM, Chirich Barreira LM, Albrecht A (2024) Spatial mRNA expression patterns of orexin receptors in the dorsal hippocampus. Sci Rep 14(1):24788. https:\/\/doi.org\/10.1038\/s41598-024-76237-9","journal-title":"Sci Rep"},{"issue":"6","key":"6839_CR74","doi-asserted-by":"publisher","first-page":"C1567","DOI":"10.1152\/ajpcell.00055.2002","volume":"283","author":"JP Kukkonen","year":"2002","unstructured":"Kukkonen JP, Holmqvist T, Ammoun S, Akerman KE (2002) Functions of the orexinergic\/hypocretinergic system. Am J Physiol Cell Physiol 283(6):C1567\u20131591. https:\/\/doi.org\/10.1152\/ajpcell.00055.2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"6839_CR75","doi-asserted-by":"publisher","unstructured":"La Torre ME, Villano I, Monda M, Messina A, Cibelli G, Valenzano A et al (2021) Role of vitamin E and the orexin system in neuroprotection. Brain Sci 11(8). https:\/\/doi.org\/10.3390\/brainsci11081098","DOI":"10.3390\/brainsci11081098"},{"issue":"11","key":"6839_CR76","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/WNR.0b013e32833bfb7c","volume":"21","author":"S Lessig","year":"2010","unstructured":"Lessig S, Ubhi K, Galasko D, Adame A, Pham E, Remidios K et al (2010) Reduced hypocretin (orexin) levels in dementia with lewy bodies. NeuroReport 21(11):756\u2013760. https:\/\/doi.org\/10.1097\/WNR.0b013e32833bfb7c","journal-title":"NeuroReport"},{"key":"6839_CR77","doi-asserted-by":"publisher","first-page":"107993","DOI":"10.1016\/j.neuropharm.2020.107993","volume":"167","author":"SB Li","year":"2020","unstructured":"Li SB, de Lecea L (2020) The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology 167:107993. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107993","journal-title":"Neuropharmacology"},{"issue":"3","key":"6839_CR78","doi-asserted-by":"publisher","first-page":"e14170","DOI":"10.1016\/j.heliyon.2023.e14170","volume":"9","author":"Y Li","year":"2023","unstructured":"Li Y, Guo Z, Cai C, Liu D, Kang Y, Liu P (2023) The orexinergic system mediates the excitatory effects of caffeine on the arousal and sympathetic activity. Heliyon 9(3):e14170. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14170","journal-title":"Heliyon"},{"key":"6839_CR79","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/7854_2016_50","volume":"33","author":"C Liguori","year":"2017","unstructured":"Liguori C (2017) Orexin and Alzheimer\u2019s disease. Curr Top Behav Neurosci 33:305\u2013322. https:\/\/doi.org\/10.1007\/7854_2016_50","journal-title":"Curr Top Behav Neurosci"},{"issue":"12","key":"6839_CR80","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1001\/jamaneurol.2014.2510","volume":"71","author":"C Liguori","year":"2014","unstructured":"Liguori C, Romigi A, Nuccetelli M, Zannino S, Sancesario G, Martorana A et al (2014) Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. Jama Neurol 71(12):1498\u20131505. https:\/\/doi.org\/10.1001\/jamaneurol.2014.2510","journal-title":"Jama Neurol"},{"key":"6839_CR81","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neurobiolaging.2016.01.007","volume":"40","author":"C Liguori","year":"2016","unstructured":"Liguori C, Nuccetelli M, Izzi F, Sancesario G, Romigi A, Martorana A et al (2016) Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer\u2019s disease. Neurobiol Aging 40:120\u2013126. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.01.007","journal-title":"Neurobiol Aging"},{"issue":"1","key":"6839_CR82","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12974-024-03231-3","volume":"21","author":"S Lin","year":"2024","unstructured":"Lin S, Shu Y, Shen R, Zhou Y, Pan H, He L et al (2024) The regulation of NFKB1 on CD200R1 expression and their potential roles in Parkinson\u2019s disease. J Neuroinflammation 21(1):229. https:\/\/doi.org\/10.1186\/s12974-024-03231-3","journal-title":"J Neuroinflammation"},{"key":"6839_CR83","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3389\/fnins.2018.00835","volume":"12","author":"MF Liu","year":"2018","unstructured":"Liu MF, Xue Y, Liu C, Liu YH, Diao HL, Wang Y et al (2018) Orexin-A exerts neuroprotective effects via OX1R in Parkinson\u2019s disease. Front Neurosci 12:835. https:\/\/doi.org\/10.3389\/fnins.2018.00835","journal-title":"Front Neurosci"},{"issue":"1","key":"6839_CR84","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3892\/ijmm.2018.3935","volume":"43","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wang F, Tang M, Zhao Y, Wang X (2019) Amyloid \u03b2 and Tau are involved in sleep disorder in Alzheimer\u2019s disease by orexin A and adenosine A(1) receptor. Int J Mol Med 43(1):435\u2013442. https:\/\/doi.org\/10.3892\/ijmm.2018.3935","journal-title":"Int J Mol Med"},{"issue":"1","key":"6839_CR85","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1021\/acsomega.9b03106","volume":"5","author":"L Liu","year":"2020","unstructured":"Liu L, Wang Q, Liu A, Lan X, Huang Y, Zhao Z et al (2020) Physiological implications of orexins\/hypocretins on energy metabolism and adipose tissue development. ACS Omega 5(1):547\u2013555. https:\/\/doi.org\/10.1021\/acsomega.9b03106","journal-title":"ACS Omega"},{"issue":"4","key":"6839_CR86","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tem.2016.02.003","volume":"27","author":"J Mattis","year":"2016","unstructured":"Mattis J, Sehgal A (2016) Circadian rhythms, sleep, and disorders of aging. Trends Endocrinol Metab 27(4):192\u2013203. https:\/\/doi.org\/10.1016\/j.tem.2016.02.003","journal-title":"Trends Endocrinol Metab"},{"key":"6839_CR87","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nlm.2017.10.014","volume":"146","author":"V Mavanji","year":"2017","unstructured":"Mavanji V, Butterick TA, Duffy CM, Nixon JP, Billington CJ, Kotz CM (2017) Orexin\/hypocretin treatment restores hippocampal-dependent memory in orexin-deficient mice. Neurobiol Learn Mem 146:21\u201330. https:\/\/doi.org\/10.1016\/j.nlm.2017.10.014","journal-title":"Neurobiol Learn Mem"},{"issue":"7","key":"6839_CR88","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s00391-023-02237-5","volume":"56","author":"G Mayer","year":"2023","unstructured":"Mayer G, Stenmanns C, Doeppner TR, Hermann DM, Gronewold J (2023) [Sleep and dementia]. Z Gerontol Geriatr 56(7):556\u2013560. https:\/\/doi.org\/10.1007\/s00391-023-02237-5","journal-title":"Z Gerontol Geriatr"},{"issue":"2","key":"6839_CR89","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainres.2005.09.028","volume":"1063","author":"A Meier","year":"2005","unstructured":"Meier A, Mollenhauer B, Cohrs S, Rodenbeck A, Jordan W, Meller J et al (2005) Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington\u2019s disease. Brain Res 1063(2):201\u2013203. https:\/\/doi.org\/10.1016\/j.brainres.2005.09.028","journal-title":"Brain Res"},{"issue":"17","key":"6839_CR90","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1523\/jneurosci.6506-10.2011","volume":"31","author":"M Mieda","year":"2011","unstructured":"Mieda M, Hasegawa E, Kisanuki YY, Sinton CM, Yanagisawa M, Sakurai T (2011) Differential roles of orexin receptor-1 and\u2013\u20092 in the regulation of non-REM and REM sleep. J Neurosci 31(17):6518\u20136526. https:\/\/doi.org\/10.1523\/jneurosci.6506-10.2011","journal-title":"J Neurosci"},{"issue":"7","key":"6839_CR91","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1089\/neu.2010.1748","volume":"28","author":"R Nardone","year":"2011","unstructured":"Nardone R, Bergmann J, Kunz A, Caleri F, Seidl M, Tezzon F et al (2011) Cortical excitability changes in patients with sleep-wake disturbances after traumatic brain injury. J Neurotrauma 28(7):1165\u20131171. https:\/\/doi.org\/10.1089\/neu.2010.1748","journal-title":"J Neurotrauma"},{"issue":"6","key":"6839_CR92","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nm0698-645c","volume":"4","author":"E Nisoli","year":"1998","unstructured":"Nisoli E, Carruba MO, Valerio A, Borsani G (1998) Hypocretins or hyporexins? Nat Med 4(6):645. https:\/\/doi.org\/10.1038\/nm0698-645c","journal-title":"Nat Med"},{"key":"6839_CR93","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.expneurol.2018.08.004","volume":"309","author":"LM Oliveira","year":"2018","unstructured":"Oliveira LM, Falquetto B, Moreira TS, Takakura AC (2018) Orexinergic neurons are involved in the chemosensory control of breathing during the dark phase in a Parkinson\u2019s disease model. Exp Neurol 309:107\u2013118. https:\/\/doi.org\/10.1016\/j.expneurol.2018.08.004","journal-title":"Exp Neurol"},{"key":"6839_CR94","doi-asserted-by":"publisher","first-page":"113110","DOI":"10.1016\/j.expneurol.2019.113110","volume":"323","author":"LM Oliveira","year":"2020","unstructured":"Oliveira LM, Henrique E, Bustelli IB, Netto NFC, Moreira TS, Takakura AC et al (2020) Depletion of hypothalamic hypocretin\/orexin neurons correlates with impaired memory in a Parkinson\u2019s disease animal model. Exp Neurol 323:113110. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113110","journal-title":"Exp Neurol"},{"issue":"3","key":"6839_CR95","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/wnl.58.3.498","volume":"58","author":"S Overeem","year":"2002","unstructured":"Overeem S, van Hilten JJ, Ripley B, Mignot E, Nishino S, Lammers GJ (2002) Normal hypocretin-1 levels in Parkinson\u2019s disease patients with excessive daytime sleepiness. Neurology 58(3):498\u2013499. https:\/\/doi.org\/10.1212\/wnl.58.3.498","journal-title":"Neurology"},{"key":"6839_CR96","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.brainres.2009.03.072","volume":"1279","author":"PN Pallier","year":"2009","unstructured":"Pallier PN, Morton AJ (2009) Management of sleep\/wake cycles improves cognitive function in a Transgenic mouse model of Huntington\u2019s disease. Brain Res 1279:90\u201398. https:\/\/doi.org\/10.1016\/j.brainres.2009.03.072","journal-title":"Brain Res"},{"issue":"29","key":"6839_CR97","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1523\/jneurosci.0649-07.2007","volume":"27","author":"PN Pallier","year":"2007","unstructured":"Pallier PN, Maywood ES, Zheng Z, Chesham JE, Inyushkin AN, Dyball R et al (2007) Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a Transgenic mouse model of Huntington\u2019s disease. J Neurosci 27(29):7869\u20137878. https:\/\/doi.org\/10.1523\/jneurosci.0649-07.2007","journal-title":"J Neurosci"},{"issue":"1","key":"6839_CR98","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00415-024-12734-1","volume":"272","author":"B Palushaj","year":"2024","unstructured":"Palushaj B, Lewis SJG, Abdelnour C (2024) What is the future for dementia with lewy bodies? J Neurol 272(1):43. https:\/\/doi.org\/10.1007\/s00415-024-12734-1","journal-title":"J Neurol"},{"key":"6839_CR99","doi-asserted-by":"publisher","first-page":"116794","DOI":"10.1016\/j.bcp.2025.116794","volume":"233","author":"SP Panda","year":"2025","unstructured":"Panda SP, Sinha S, Kesharwani A, Kumar S, Singh M, Kondepudi GM et al (2025) Role of OX\/OXR cascade in insomnia and sleep deprivation link Alzheimer\u2019s disease and Parkinson\u2019s disease: therapeutic avenue of dual OXR antagonist (DORA). Biochem Pharmacol 233:116794. https:\/\/doi.org\/10.1016\/j.bcp.2025.116794","journal-title":"Biochem Pharmacol"},{"key":"6839_CR100","doi-asserted-by":"publisher","unstructured":"Parent MJ, Bedard MA, Aliaga A, Minuzzi L, Mechawar N, Soucy JP et al (2013) Cholinergic depletion in Alzheimer\u2019s disease shown by [ (18) F]FEOBV Autoradiography. Int J Mol Imaging 2013:205045. https:\/\/doi.org\/10.1155\/2013\/205045","DOI":"10.1155\/2013\/205045"},{"issue":"2","key":"6839_CR101","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/rej.2016.1836","volume":"20","author":"H Pasban-Aliabadi","year":"2017","unstructured":"Pasban-Aliabadi H, Esmaeili-Mahani S, Abbasnejad M (2017) Orexin-A protects human neuroblastoma SH-SY5Y cells against 6-hydroxydopamine-induced neurotoxicity: involvement of PKC and PI3K signaling pathways. Rejuvenation Res 20(2):125\u2013133. https:\/\/doi.org\/10.1089\/rej.2016.1836","journal-title":"Rejuvenation Res"},{"issue":"1","key":"6839_CR102","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/hmg\/ddi004","volume":"14","author":"A Peters\u00e9n","year":"2005","unstructured":"Peters\u00e9n A, Gil J, Maat-Schieman ML, Bj\u00f6rkqvist M, Tanila H, Ara\u00fajo IM et al (2005) Orexin loss in Huntington\u2019s disease. Hum Mol Genet 14(1):39\u201347. https:\/\/doi.org\/10.1093\/hmg\/ddi004","journal-title":"Hum Mol Genet"},{"issue":"23","key":"6839_CR103","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1523\/jneurosci.18-23-09996.1998","volume":"18","author":"C Peyron","year":"1998","unstructured":"Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG et al (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18(23):9996\u201310015. https:\/\/doi.org\/10.1523\/jneurosci.18-23-09996.1998","journal-title":"J Neurosci"},{"key":"6839_CR104","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainres.2014.10.041","volume":"1594","author":"PT Piantadosi","year":"2015","unstructured":"Piantadosi PT, Holmes A, Roberts BM, Bailey AM (2015) Orexin receptor activity in the basal forebrain alters performance on an olfactory discrimination task. Brain Res 1594:215\u2013222. https:\/\/doi.org\/10.1016\/j.brainres.2014.10.041","journal-title":"Brain Res"},{"key":"6839_CR105","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","volume":"30","author":"L Pini","year":"2016","unstructured":"Pini L, Pievani M, Bocchetta M, Altomare D, Bosco P, Cavedo E et al (2016) Brain atrophy in Alzheimer\u2019s disease and aging. Ageing Res Rev 30:25\u201348. https:\/\/doi.org\/10.1016\/j.arr.2016.01.002","journal-title":"Ageing Res Rev"},{"issue":"9","key":"6839_CR106","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.metabol.2016.05.018","volume":"65","author":"C Procaccini","year":"2016","unstructured":"Procaccini C, Santopaolo M, Faicchia D, Colamatteo A, Formisano L, de Candia P et al (2016) Role of metabolism in neurodegenerative disorders. Metabolism 65(9):1376\u20131390. https:\/\/doi.org\/10.1016\/j.metabol.2016.05.018","journal-title":"Metabolism"},{"key":"6839_CR107","doi-asserted-by":"publisher","unstructured":"Ra\u00efch I, Rebassa JB, Lillo J, Cordomi A, Rivas-Santisteban R, Lillo A et al (2022) Antagonization of OX(1) receptor potentiates CB(2) receptor function in microglia from APP(Sw\/Ind) mice model. Int J Mol Sci 23(21). https:\/\/doi.org\/10.3390\/ijms232112801","DOI":"10.3390\/ijms232112801"},{"key":"6839_CR108","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.npep.2015.03.002","volume":"50","author":"R Raoof","year":"2015","unstructured":"Raoof R, Esmaeili-Mahani S, Abbasnejad M, Raoof M, Sheibani V, Kooshki R et al (2015) Changes in hippocampal orexin 1 receptor expression involved in tooth pain-induced learning and memory impairment in rats. Neuropeptides 50:9\u201316. https:\/\/doi.org\/10.1016\/j.npep.2015.03.002","journal-title":"Neuropeptides"},{"issue":"4","key":"6839_CR109","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/cns.12844","volume":"24","author":"A Reiner","year":"2018","unstructured":"Reiner A, Deng YP (2018) Disrupted striatal neuron inputs and outputs in Huntington\u2019s disease. CNS Neurosci Ther 24(4):250\u2013280. https:\/\/doi.org\/10.1111\/cns.12844","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"6839_CR110","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1212\/wnl.57.12.2253","volume":"57","author":"B Ripley","year":"2001","unstructured":"Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, Yesavage J et al (2001) CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions. Neurology 57(12):2253\u20132258. https:\/\/doi.org\/10.1212\/wnl.57.12.2253","journal-title":"Neurology"},{"issue":"13","key":"6839_CR111","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1084\/jem.20141788","volume":"211","author":"JH Roh","year":"2014","unstructured":"Roh JH, Jiang H, Finn MB, Stewart FR, Mahan TE, Cirrito JR et al (2014) Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer\u2019s disease. J Exp Med 211(13):2487\u20132496. https:\/\/doi.org\/10.1084\/jem.20141788","journal-title":"J Exp Med"},{"issue":"4","key":"6839_CR112","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H et al (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92(4):573\u2013585. https:\/\/doi.org\/10.1016\/s0092-8674(00)80949-6","journal-title":"Cell"},{"key":"6839_CR113","doi-asserted-by":"publisher","unstructured":"Schmidt FM, Kratzsch J, Gertz HJ, Tittmann M, Jahn I, Pietsch UC et al (2013) Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer\u2019s disease. PLoS ONE 8(5):e63136. https:\/\/doi.org\/10.1371\/journal.pone.0063136","DOI":"10.1371\/journal.pone.0063136"},{"issue":"2","key":"6839_CR114","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00429-011-0343-8","volume":"217","author":"O Schmitt","year":"2012","unstructured":"Schmitt O, Usunoff KG, Lazarov NE, Itzev DE, Eipert P, Rolfs A et al (2012) Orexinergic innervation of the extended amygdala and basal ganglia in the rat. Brain Struct Funct 217(2):233\u2013256. https:\/\/doi.org\/10.1007\/s00429-011-0343-8","journal-title":"Brain Struct Funct"},{"issue":"50","key":"6839_CR115","doi-asserted-by":"publisher","first-page":"20260","DOI":"10.1073\/pnas.1320325110","volume":"110","author":"RM Sears","year":"2013","unstructured":"Sears RM, Fink AE, Wigestrand MB, Farb CR, de Lecea L, Ledoux JE (2013) Orexin\/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus. Proc Natl Acad Sci U S A 110(50):20260\u201320265. https:\/\/doi.org\/10.1073\/pnas.1320325110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6839_CR116","doi-asserted-by":"publisher","unstructured":"Sharma C, Kim S, Nam Y, Jung UJ, Kim SR (2021) Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer\u2019s disease. Int J Mol Sci 22(9). https:\/\/doi.org\/10.3390\/ijms22094850","DOI":"10.3390\/ijms22094850"},{"issue":"3","key":"6839_CR117","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbrc.2008.11.051","volume":"378","author":"HS Shin","year":"2009","unstructured":"Shin HS, Cho HS, Sung KW, Yoon BJ (2009) Orexin-A increases cell surface expression of AMPA receptors in the striatum. Biochem Biophys Res Commun 378(3):409\u2013413. https:\/\/doi.org\/10.1016\/j.bbrc.2008.11.051","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"6839_CR118","doi-asserted-by":"publisher","first-page":"e95259","DOI":"10.1371\/journal.pone.0095259","volume":"9","author":"Q Shu","year":"2014","unstructured":"Shu Q, Hu ZL, Huang C, Yu XW, Fan H, Yang JW et al (2014) Orexin-A promotes cell migration in cultured rat astrocytes via Ca2+-dependent PKC\u03b1 and ERK1\/2 signals. PLoS ONE 9(4):e95259. https:\/\/doi.org\/10.1371\/journal.pone.0095259","journal-title":"PLoS ONE"},{"issue":"10","key":"6839_CR119","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2174\/156720512804142840","volume":"9","author":"D Slats","year":"2012","unstructured":"Slats D, Claassen JA, Lammers GJ, Melis RJ, Verbeek MM, Overeem S (2012) Association between hypocretin-1 and amyloid-\u03b242 cerebrospinal fluid levels in Alzheimer\u2019s disease and healthy controls. Curr Alzheimer Res 9(10):1119\u20131125. https:\/\/doi.org\/10.2174\/156720512804142840","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"6839_CR120","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1148\/radiol.2482070938","volume":"248","author":"JD Sluimer","year":"2008","unstructured":"Sluimer JD, van der Flier WM, Karas GB, Fox NC, Scheltens P, Barkhof F et al (2008) Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology 248(2):590\u2013598. https:\/\/doi.org\/10.1148\/radiol.2482070938","journal-title":"Radiology"},{"key":"6839_CR121","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fnins.2020.00691","volume":"14","author":"S Soya","year":"2020","unstructured":"Soya S, Sakurai T (2020) Evolution of orexin neuropeptide system: structure and function. Front Neurosci 14:691. https:\/\/doi.org\/10.3389\/fnins.2020.00691","journal-title":"Front Neurosci"},{"issue":"36","key":"6839_CR122","doi-asserted-by":"publisher","first-page":"14549","DOI":"10.1523\/jneurosci.1130-13.2013","volume":"33","author":"S Soya","year":"2013","unstructured":"Soya S, Shoji H, Hasegawa E, Hondo M, Miyakawa T, Yanagisawa M et al (2013) Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear memory consolidation. J Neurosci 33(36):14549\u201314557. https:\/\/doi.org\/10.1523\/jneurosci.1130-13.2013","journal-title":"J Neurosci"},{"issue":"1","key":"6839_CR123","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/s41467-017-01782-z","volume":"8","author":"S Soya","year":"2017","unstructured":"Soya S, Takahashi TM, McHugh TJ, Maejima T, Herlitze S, Abe M et al (2017) Orexin modulates behavioral fear expression through the locus coeruleus. Nat Commun 8(1):1606. https:\/\/doi.org\/10.1038\/s41467-017-01782-z","journal-title":"Nat Commun"},{"issue":"5","key":"6839_CR124","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/syn.21533","volume":"66","author":"EM Stanley","year":"2012","unstructured":"Stanley EM, Fadel J (2012) Aging-related deficits in orexin\/hypocretin modulation of the septohippocampal cholinergic system. Synapse 66(5):445\u2013452. https:\/\/doi.org\/10.1002\/syn.21533","journal-title":"Synapse"},{"issue":"1","key":"6839_CR125","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13041-019-0514-8","volume":"12","author":"M Stanojlovic","year":"2019","unstructured":"Stanojlovic M, Pallais JP, Lee MK, Kotz CM (2019a) Pharmacological and chemogenetic orexin\/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson\u2019s disease. Mol Brain 12(1):87. https:\/\/doi.org\/10.1186\/s13041-019-0514-8","journal-title":"Mol Brain"},{"issue":"12","key":"6839_CR126","doi-asserted-by":"publisher","first-page":"8435","DOI":"10.1007\/s12035-019-01682-x","volume":"56","author":"M Stanojlovic","year":"2019","unstructured":"Stanojlovic M, Pallais Yllescas JP Jr., Vijayakumar A, Kotz C (2019b) Early sociability and social memory impairment in the A53T mouse model of Parkinson\u2019s disease are ameliorated by chemogenetic modulation of orexin neuron activity. Mol Neurobiol 56(12):8435\u20138450. https:\/\/doi.org\/10.1007\/s12035-019-01682-x","journal-title":"Mol Neurobiol"},{"key":"6839_CR127","doi-asserted-by":"publisher","unstructured":"Stanojlovic M, Pallais JP, Kotz CM (2021) Inhibition of orexin\/hypocretin neurons ameliorates elevated physical activity and energy expenditure in the A53T mouse model of Parkinson\u2019s disease. Int J Mol Sci 22(2). https:\/\/doi.org\/10.3390\/ijms22020795","DOI":"10.3390\/ijms22020795"},{"issue":"1","key":"6839_CR128","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00005072-199901000-00004","volume":"58","author":"EG Stopa","year":"1999","unstructured":"Stopa EG, Volicer L, Kuo-Leblanc V, Harper D, Lathi D, Tate B et al (1999) Pathologic evaluation of the human Suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 58(1):29\u201339. https:\/\/doi.org\/10.1097\/00005072-199901000-00004","journal-title":"J Neuropathol Exp Neurol"},{"key":"6839_CR129","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 106\u2013107:17\u201332. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.04.004","journal-title":"Prog Neurobiol"},{"key":"6839_CR130","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.neuro.25.112701.142826","volume":"25","author":"S Taheri","year":"2002","unstructured":"Taheri S, Zeitzer JM, Mignot E (2002) The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci 25:283\u2013313. https:\/\/doi.org\/10.1146\/annurev.neuro.25.112701.142826","journal-title":"Annu Rev Neurosci"},{"key":"6839_CR131","doi-asserted-by":"publisher","first-page":"101066","DOI":"10.1016\/j.yfrne.2023.101066","volume":"69","author":"M Ten-Blanco","year":"2023","unstructured":"Ten-Blanco M, Flores \u00c1, Cristino L, Pereda-P\u00e9rez I, Berrendero F (2023) Targeting the orexin\/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: from animal to clinical studies. Front Neuroendocrinol 69:101066. https:\/\/doi.org\/10.1016\/j.yfrne.2023.101066","journal-title":"Front Neuroendocrinol"},{"issue":"1","key":"6839_CR132","doi-asserted-by":"publisher","first-page":"15964","DOI":"10.1038\/s41598-024-64817-8","volume":"14","author":"M Terada","year":"2024","unstructured":"Terada M, Mitsukawa K, Nakakariya M, Koike T, Kimura H (2024) Effects of an OX2R agonist on migration and removal of Tau from mouse brain. Sci Rep 14(1):15964. https:\/\/doi.org\/10.1038\/s41598-024-64817-8","journal-title":"Sci Rep"},{"issue":"Pt 6","key":"6839_CR133","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/brain\/awm097","volume":"130","author":"TC Thannickal","year":"2007","unstructured":"Thannickal TC, Lai YY, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson\u2019s disease. Brain 130(Pt 6):1586\u20131595. https:\/\/doi.org\/10.1093\/brain\/awm097","journal-title":"Brain"},{"key":"6839_CR134","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000514960","volume":"45","author":"B Toor","year":"2021","unstructured":"Toor B, Ray LB, Pozzobon A, Fogel SM (2021) Sleep, orexin and cognition. Front Neurol Neurosci 45:38\u201351. https:\/\/doi.org\/10.1159\/000514960","journal-title":"Front Neurol Neurosci"},{"issue":"1","key":"6839_CR135","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12974-020-01831-3","volume":"17","author":"K Toriuchi","year":"2020","unstructured":"Toriuchi K, Kakita H, Tamura T, Takeshita S, Yamada Y, Aoyama M (2020) Prolonged astrocyte-derived erythropoietin expression attenuates neuronal damage under hypothermic conditions. J Neuroinflammation 17(1):141. https:\/\/doi.org\/10.1186\/s12974-020-01831-3","journal-title":"J Neuroinflammation"},{"issue":"5","key":"6839_CR136","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1507\/endocrj.ej12-0030","volume":"59","author":"H Tsuneki","year":"2012","unstructured":"Tsuneki H, Wada T, Sasaoka T (2012) Role of orexin in the central regulation of glucose and energy homeostasis. Endocr J 59(5):365\u2013374. https:\/\/doi.org\/10.1507\/endocrj.ej12-0030","journal-title":"Endocr J"},{"issue":"11","key":"6839_CR137","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1210\/en.2016-1404","volume":"157","author":"H Tsuneki","year":"2016","unstructured":"Tsuneki H, Kon K, Ito H, Yamazaki M, Takahara S, Toyooka N et al (2016) Timed Inhibition of orexin system by suvorexant improved sleep and glucose metabolism in type 2 diabetic db\/db mice. Endocrinology 157(11):4146\u20134157. https:\/\/doi.org\/10.1210\/en.2016-1404","journal-title":"Endocrinology"},{"issue":"179","key":"6839_CR138","doi-asserted-by":"publisher","first-page":"179ra144","DOI":"10.1126\/scitranslmed.3005213","volume":"5","author":"JM Uslaner","year":"2013","unstructured":"Uslaner JM, Tye SJ, Eddins DM, Wang X, Fox SV, Savitz AT et al (2013) Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition. Sci Transl Med 5(179):179ra144. https:\/\/doi.org\/10.1126\/scitranslmed.3005213","journal-title":"Sci Transl Med"},{"key":"6839_CR139","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnbeh.2017.00010","volume":"11","author":"I Villano","year":"2017","unstructured":"Villano I, Messina A, Valenzano A, Moscatelli F, Esposito T, Monda V et al (2017) Basal forebrain cholinergic system and orexin neurons: effects on attention. Front Behav Neurosci 11:10. https:\/\/doi.org\/10.3389\/fnbeh.2017.00010","journal-title":"Front Behav Neurosci"},{"key":"6839_CR140","doi-asserted-by":"publisher","unstructured":"Vincenzi F, Pasquini S, Setti S, Salati S, Cadossi R, Borea PA et al (2020) Pulsed electromagnetic fields stimulate HIF-1\u03b1-Independent VEGF release in 1321N1 human astrocytes protecting Neuron-Like SH-SY5Y cells from oxygen-glucose deprivation. Int J Mol Sci 21(21). https:\/\/doi.org\/10.3390\/ijms21218053","DOI":"10.3390\/ijms21218053"},{"issue":"12","key":"6839_CR141","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/jnr.24508","volume":"97","author":"KS Vitanova","year":"2019","unstructured":"Vitanova KS, Stringer KM, Benitez DP, Brenton J, Cummings DM (2019) Dementia associated with disorders of the basal ganglia. J Neurosci Res 97(12):1728\u20131741. https:\/\/doi.org\/10.1002\/jnr.24508","journal-title":"J Neurosci Res"},{"key":"6839_CR142","doi-asserted-by":"publisher","unstructured":"Vraka K, Mytilinaios D, Katsenos AP, Serbis A, Baloyiannis S, Bellos S et al (2023) Cellular localization of orexin 1 receptor in human hypothalamus and morphological analysis of neurons expressing the receptor. Biomolecules 13(4). https:\/\/doi.org\/10.3390\/biom13040592","DOI":"10.3390\/biom13040592"},{"issue":"34","key":"6839_CR143","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1523\/jneurosci.1587-04.2004","volume":"24","author":"SG Walling","year":"2004","unstructured":"Walling SG, Nutt DJ, Lalies MD, Harley CW (2004) Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrus. J Neurosci 24(34):7421\u20137426. https:\/\/doi.org\/10.1523\/jneurosci.1587-04.2004","journal-title":"J Neurosci"},{"issue":"4","key":"6839_CR144","doi-asserted-by":"publisher","first-page":"C800","DOI":"10.1152\/ajpcell.00125.2019","volume":"317","author":"Y Wang","year":"2019","unstructured":"Wang Y, Chen AQ, Xue Y, Liu MF, Liu C, Liu YH et al (2019) Orexins alleviate motor deficits via increasing firing activity of pallidal neurons in a mouse model of Parkinson\u2019s disease. Am J Physiol Cell Physiol 317(4):C800\u2013c812. https:\/\/doi.org\/10.1152\/ajpcell.00125.2019","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"6839_CR145","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.3390\/ijms11114257","volume":"11","author":"M Waragai","year":"2010","unstructured":"Waragai M, Sekiyama K, Sekigawa A, Takamatsu Y, Fujita M, Hashimoto M (2010) \u03b1-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson\u2019s disease. Int J Mol Sci 11(11):4257\u20134266. https:\/\/doi.org\/10.3390\/ijms11114257","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6839_CR146","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/jad-2012-111655","volume":"29","author":"M Wennstr\u00f6m","year":"2012","unstructured":"Wennstr\u00f6m M, Londos E, Minthon L, Nielsen HM (2012) Altered CSF orexin and \u03b1-synuclein levels in dementia patients. J Alzheimers Dis 29(1):125\u2013132. https:\/\/doi.org\/10.3233\/jad-2012-111655","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"6839_CR147","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1365-2869.2012.01027.x","volume":"21","author":"M Wienecke","year":"2012","unstructured":"Wienecke M, Werth E, Poryazova R, Baumann-Vogel H, Bassetti CL, Weller M et al (2012) Progressive dopamine and hypocretin deficiencies in Parkinson\u2019s disease: is there an impact on sleep and wakefulness? J Sleep Res 21(6):710\u2013717. https:\/\/doi.org\/10.1111\/j.1365-2869.2012.01027.x","journal-title":"J Sleep Res"},{"issue":"3","key":"6839_CR148","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2011.02.006","volume":"42","author":"RH Williams","year":"2011","unstructured":"Williams RH, Morton AJ, Burdakov D (2011) Paradoxical function of orexin\/hypocretin circuits in a mouse model of Huntington\u2019s disease. Neurobiol Dis 42(3):438\u2013445. https:\/\/doi.org\/10.1016\/j.nbd.2011.02.006","journal-title":"Neurobiol Dis"},{"issue":"11","key":"6839_CR149","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1038\/s41591-023-02566-3","volume":"29","author":"DK Wilton","year":"2023","unstructured":"Wilton DK, Mastro K, Heller MD, Gergits FW, Willing CR, Fahey JB et al (2023) Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington\u2019s disease. Nat Med 29(11):2866\u20132884. https:\/\/doi.org\/10.1038\/s41591-023-02566-3","journal-title":"Nat Med"},{"issue":"5","key":"6839_CR150","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/s1474-4422(16)00062-4","volume":"15","author":"B Winblad","year":"2016","unstructured":"Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H et al (2016) Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society. Lancet Neurol 15(5):455\u2013532. https:\/\/doi.org\/10.1016\/s1474-4422(16)00062-4","journal-title":"Lancet Neurol"},{"key":"6839_CR151","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.10.021","volume":"67","author":"F Xiao","year":"2013","unstructured":"Xiao F, Jiang M, Du D, Xia C, Wang J, Cao Y et al (2013) Orexin A regulates cardiovascular responses in stress-induced hypertensive rats. Neuropharmacology 67:16\u201324. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.10.021","journal-title":"Neuropharmacology"},{"issue":"6156","key":"6839_CR152","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M et al (2013) Sleep drives metabolite clearance from the adult brain. Science 342(6156):373\u2013377. https:\/\/doi.org\/10.1126\/science.1241224","journal-title":"Science"},{"issue":"3","key":"6839_CR153","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/strokeaha.112.681700","volume":"44","author":"X Xiong","year":"2013","unstructured":"Xiong X, White RE, Xu L, Yang L, Sun X, Zou B et al (2013) Mitigation of murine focal cerebral ischemia by the hypocretin\/orexin system is associated with reduced inflammation. Stroke 44(3):764\u2013770. https:\/\/doi.org\/10.1161\/strokeaha.112.681700","journal-title":"Stroke"},{"issue":"1","key":"6839_CR154","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/gt.2009.113","volume":"17","author":"YQ Xue","year":"2010","unstructured":"Xue YQ, Ma BF, Zhao LR, Tatom JB, Li B, Jiang LX et al (2010) AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of parkinson\u2019s disease. Gene Ther 17(1):83\u201394. https:\/\/doi.org\/10.1038\/gt.2009.113","journal-title":"Gene Ther"},{"issue":"5","key":"6839_CR155","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/ejn.13323","volume":"44","author":"Y Xue","year":"2016","unstructured":"Xue Y, Yang YT, Liu HY, Chen WF, Chen AQ, Sheng Q et al (2016) Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats. Eur J Neurosci 44(5):2247\u20132257. https:\/\/doi.org\/10.1111\/ejn.13323","journal-title":"Eur J Neurosci"},{"issue":"1\u20132","key":"6839_CR156","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/s0006-8993(99)01905-8","volume":"849","author":"A Yamanaka","year":"1999","unstructured":"Yamanaka A, Sakurai T, Katsumoto T, Yanagisawa M, Goto K (1999) Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res 849(1\u20132):248\u2013252. https:\/\/doi.org\/10.1016\/s0006-8993(99)01905-8","journal-title":"Brain Res"},{"issue":"12","key":"6839_CR157","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1523\/jneurosci.3200-12.2013","volume":"33","author":"L Yang","year":"2013","unstructured":"Yang L, Zou B, Xiong X, Pascual C, Xie J, Malik A et al (2013) Hypocretin\/orexin neurons contribute to hippocampus-dependent social memory and synaptic plasticity in mice. J Neurosci 33(12):5275\u20135284. https:\/\/doi.org\/10.1523\/jneurosci.3200-12.2013","journal-title":"J Neurosci"},{"key":"6839_CR158","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fnins.2019.00195","volume":"13","author":"YL Yang","year":"2019","unstructured":"Yang YL, Ran XR, Li Y, Zhou L, Zheng LF, Han Y et al (2019) Expression of dopamine receptors in the lateral hypothalamic nucleus and their potential regulation of gastric motility in rats with lesions of bilateral substantia Nigra. Front Neurosci 13:195. https:\/\/doi.org\/10.3389\/fnins.2019.00195","journal-title":"Front Neurosci"},{"key":"6839_CR159","doi-asserted-by":"publisher","unstructured":"Yang J, Pourzinal D, Byrne GJ, McMahon KL, Copland DA, O\u2019Sullivan JD et al (2023) Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson\u2019s disease. Int J Geriatr Psychiatry 38(6):e5955. https:\/\/doi.org\/10.1002\/gps.5955","DOI":"10.1002\/gps.5955"},{"issue":"1\u20132","key":"6839_CR160","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jns.2006.08.004","volume":"250","author":"K Yasui","year":"2006","unstructured":"Yasui K, Inoue Y, Kanbayashi T, Nomura T, Kusumi M, Nakashima K (2006) CSF orexin levels of Parkinson\u2019s disease, dementia with lewy bodies, progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 250(1\u20132):120\u2013123. https:\/\/doi.org\/10.1016\/j.jns.2006.08.004","journal-title":"J Neurol Sci"},{"issue":"1","key":"6839_CR161","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10048-012-0350-9","volume":"14","author":"M Yusuf","year":"2013","unstructured":"Yusuf M, Leung K, Morris KJ, Volpi EV (2013) Comprehensive cytogenomic profile of the in vitro neuronal model SH-SY5Y. Neurogenetics 14(1):63\u201370. https:\/\/doi.org\/10.1007\/s10048-012-0350-9","journal-title":"Neurogenetics"},{"issue":"4","key":"6839_CR162","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00213-015-4139-z","volume":"233","author":"KN Zajo","year":"2016","unstructured":"Zajo KN, Fadel JR, Burk JA (2016) Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neurons. Psychopharmacology 233(4):639\u2013647. https:\/\/doi.org\/10.1007\/s00213-015-4139-z","journal-title":"Psychopharmacology"},{"key":"6839_CR163","doi-asserted-by":"publisher","first-page":"1456948","DOI":"10.3389\/fendo.2024.1456948","volume":"15","author":"J Zeng","year":"2024","unstructured":"Zeng J, Cheong LYT, Lo CH (2024) Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration. Front Endocrinol (Lausanne) 15:1456948. https:\/\/doi.org\/10.3389\/fendo.2024.1456948","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"6839_CR164","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s00330-023-10122-3","volume":"34","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang Y, Jiao B, Wang Z, Shi J, Zhang Y et al (2024) Glymphatic system impairment in Alzheimer\u2019s disease: associations with perivascular space volume and cognitive function. Eur Radiol 34(2):1314\u20131323. https:\/\/doi.org\/10.1007\/s00330-023-10122-3","journal-title":"Eur Radiol"},{"key":"6839_CR165","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neurobiolaging.2020.02.020","volume":"91","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yan XD, Wang C, He YX, Li YY, Zhang J et al (2020) Suvorexant ameliorates cognitive impairments and pathology in APP\/PS1 Transgenic mice. Neurobiol Aging 91:66\u201375. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.02.020","journal-title":"Neurobiol Aging"},{"issue":"3","key":"6839_CR166","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/1440-1681.13424","volume":"48","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Xu L, Cao D, Song C, Wang Y, Li M et al (2021) Effect of orexin-A on mitochondrial biogenesis, mitophagy and structure in HEK293-APPSWE cell model of Alzheimer\u2019s disease. Clin Exp Pharmacol Physiol 48(3):355\u2013360. https:\/\/doi.org\/10.1111\/1440-1681.13424","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"6839_CR167","doi-asserted-by":"publisher","first-page":"1529981","DOI":"10.3389\/fphys.2025.1529981","volume":"16","author":"C Zhuang","year":"2025","unstructured":"Zhuang C, Yan H, Lu J, Zhou Y, Liu Y, Shi G et al (2025) Compensatory enhancement of orexinergic system functionality induced by amyloid-\u03b2 protein: a neuroprotective response in Alzheimer\u2019s disease. Front Physiol 16:1529981. https:\/\/doi.org\/10.3389\/fphys.2025.1529981","journal-title":"Front Physiol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06839-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06839-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06839-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:24:18Z","timestamp":1758270258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-025-06839-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":167,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["6839"],"URL":"https:\/\/doi.org\/10.1007\/s00213-025-06839-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}